In this presentation from Glaucoma Subspecialty Day 2022, Dr. Prem Subramanian reviews what is old and new in thyroid eye disease, focusing on nonsurgical treatment.

Weekly case challenge

Manipulating an existing Ahmed glaucoma valve (AGV) can decrease postsurgical drops and achieve additional intraocular pressure (IOP) lowering without targeting additional tissues of the eye to lower IOP. This video demonstrates a novel AGV surgical augmentation approach.

Dr. Lorraine Provencher moderates this journal club with Dr. Russell N. Van Gelder discussing a Mendelian randomization study on habitual coffee consumption increases risk of primary open-angle glaucoma.

In this interview from AAO 2022, Glaucoma Subspecialty Day co-chair Dr. Kelly Muir highlights the keynote talk by Dr. Anne Coleman on the effect of neighborhood on a patient's health and care.

Long-term IOP elevations after anti-VEGF injections in patients with glaucoma and diabetic macular edema (DME) were observed in order to clarify the risks and benefits of anti-VEGF therapy.

Measurements of IOP made with commonly used tonometers before and after myopic photorefractive keratectomy (PRK) were analyzed to compare the accuracy of these tools.

In this webinar, Drs. Larsen, Ou, Patel, Smith, Teng, and Zhao review the most current information on the medical and surgical management of glaucoma.

In this journal club and late-breaking session at Glaucoma Subspecialty Day 2021, experts discuss the sustained-release bimatoprost implant, as well as surgical approach and other topics.